Particulars (Rupees in Crores.) | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Gross Sales | 449.51 | 430.67 | 361.84 | 450.13 | 377.92 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 449.51 | 430.67 | 361.84 | 450.13 | 377.92 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | -0.14 | 11.07 | 3.98 | 2.99 | 3.1 |
Total Income | 449.37 | 441.74 | 365.82 | 453.12 | 381.02 |
Total Expenditure | 336.94 | 324.09 | 276.83 | 316.32 | 281.65 |
PBIDT | 112.43 | 117.65 | 88.99 | 136.81 | 99.37 |
Interest | 10.72 | 9.02 | 11.02 | 20.7 | 23.55 |
PBDT | 101.71 | 108.63 | 77.97 | 116.11 | 75.82 |
Depreciation | 8.58 | 9.22 | 8.41 | 8.48 | 8.65 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 19.96 | 22.88 | 16.06 | 20.78 | 18.62 |
Deferred Tax | -7.07 | 0.66 | 2.58 | -12.8 | 0.51 |
Reported Profit After Tax | 80.24 | 75.88 | 50.92 | 99.64 | 48.04 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 80.24 | 75.88 | 50.92 | 99.64 | 48.04 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 80.24 | 75.88 | 50.92 | 99.64 | 48.04 |
EPS (Unit Curr.) | 3.53 | 3.33 | 2.24 | 4.45 | 2.45 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 45.49 | 45.49 | 45.49 | 45.49 | 39.44 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 25.01 | 27.31 | 24.59 | 30.39 | 26.29 |
PBDTM(%) | 22.62 | 25.22 | 21.54 | 25.79 | 20.06 |
PATM(%) | 17.85 | 17.61 | 14.07 | 22.13 | 12.71 |
At the end of the June quarter, Paresh owned 1.12% of Sun Pharma Advanced Research, while his brother Vijay owned 1.13% of the company.
Here are some of the stocks that may see significant price movement today: HPCL, PNB Housing, Colgate-Palmolive, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.